B M Pfitzner
Overview
Explore the profile of B M Pfitzner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
111
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Eisenhardt A, Schmid A, Esser J, Brugger Z, Lausch U, Kiefer J, et al.
Mol Cancer
. 2022 Feb;
21(1):50.
PMID: 35164780
No abstract available.
2.
Villegas S, Darb-Esfahani S, von Minckwitz G, Huober J, Weber K, Marme F, et al.
Breast Cancer Res Treat
. 2017 Nov;
168(1):179-187.
PMID: 29177689
Purpose: Hormone receptor (HR)-positive breast cancer (BC) shows a poor response to neoadjuvant chemotherapy (NACT). New treatment targets like the Cyclin D1-CDK4/CDK6 complex are promising adjuvant/post-neoadjuvant therapeutic strategies. Evaluating Cyclin...
3.
Schreiner M, Sanad W, Pfitzner B, Baumann G, Knebel F
Curr Oncol
. 2015 Dec;
22(5):e387-90.
PMID: 26628882
Primary intravascular synovial sarcoma is a rare malignancy with only a few cases documented in the literature. On presentation, this tumour usually resembles a deep venous thrombosis (dvt) or pulmonary...
4.
Dietel M, Johrens K, Laffert M, Hummel M, Blaker H, Pfitzner B, et al.
Cancer Gene Ther
. 2015 Sep;
22(9):417-30.
PMID: 26358176
In April 2013 our group published a review on predictive molecular pathology in this journal. Although only 2 years have passed many new facts and stimulating developments have happened in...
5.
Denkert C, Pfitzner B, Heppner B, Dietel M
Pathologe
. 2015 Apr;
36(2):145-53.
PMID: 25836324
Gene expression arrays are currently used to guide therapy decisions in breast cancer. The indications for gene expression tests are especially important in the group of hormone receptor negative, HER2...
6.
Lindner J, Loibl S, Denkert C, Ataseven B, Fasching P, Pfitzner B, et al.
Ann Oncol
. 2014 Oct;
26(1):95-100.
PMID: 25355716
Background: Secreted protein acidic and rich in cysteine (SPARC) has been suggested as a new biomarker and therapeutic target in breast cancer, as well as other tumor types. Patients And...